Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.56%.
The rapid advancement of Artificial Intelligence has moved us from simple chatbots to autonomous agents. These agents do not just answer questions; they plan, use tools, and execute tasks with minimal ...
Citadel Securities’ new report challenges Citrini Research’s alarming AI forecast, offering a cautious outlook on automation, ...
Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...
In the biotech sphere, ARK continued its accumulation of CRISPR Therapeutics AG (NASDAQ:CRSP) by acquiring 37,075 shares worth $1.97 million. This purchase is part of a broader strategy, as ARK has ...
Are AI job loss fears overblown? A new 2026 report says software hiring is rebounding, daily AI use is flat, and compute costs may cap rapid white-collar displacement.
It’s more than just code. Scientists have found a way to "dial" the hidden personalities of AI, from conspiracy theorists to ...
A memo envisioning an AI-driven economic collapse logged 9.5 million views on X in 48 hours. Michael Burry amplified it. The Dow fell over 800 points. Are you listening?